A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil.
The therapeutic profile of many anti-cancer drugs has been improved by their modified distribution through a colloidal carrier system. Hence, bovine serum albumin nanospheres containing 5-fluorouracil were prepared by pH-coacervation methods. To select the most suitable cryoprotector for the formulated nanosphere system, a study on the effect of cryoprotectors in the prevention of particle agglomeration was done. Using glucose and mannitol at various concentrations during freeze drying, glucose at a concentration of 5% was observed to be relatively more effective in the prevention of particle agglomeration than the other cryoprotectors. The carrier capacity was determined through the drug-to-albumin ratio. The particle size of all the drug-loaded batches was analyzed before and after freeze drying. The batch of nanospheres with uniform size distribution, and highest drug loading, was used for other subsequent studies. The effect of surfactant in drug loading was estimated through various concentrations of sodium lauryl sulfate, and it was observed that the surfactant has no influence on drug loading at the selected concentrations. The batch of nanospheres with highest drug loading was evaluated for its in-vitro release, and the drug release was found to be in a bi-phasic pattern. To evaluate the efficacy of 5-fluorouracil-loaded nanospheres against cancer cells, an in vitro cytotoxicity study was carried out using HEp-2 cell lines. The nanosphere-bound drug was observed to produce a better cytotoxic effect than the free drug. The anti-tumor efficacy of drug-loaded nanosphere was investigated in DLA tumor-induced mice models, and the percentage tumor inhibition was relatively higher in animals treated with nanosphere-bound drug than with free drug.
Santhi
K
K
Center for Research and Post-Graduate Studies, JSS College of Pharmacy, Rocklands, Ooty 1, India.
Dhanaraj
S A
SA
Joseph
Vinod
V
Ponnusankar
S
S
Suresh
B
B
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000737:chemistry* / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D016503:Drug Delivery Systems; D005472:Fluorouracil / Q000737:chemistry / Q000494:pharmacology*; D005612:Freeze Drying; D006863:Hydrogen-Ion Concentration; D051379:Mice; D036103:Nanotechnology; D010316:Particle Size; D012710:Serum Albumin, Bovine / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry; D014407:Tumor Cells, Cultured
D000964:Antimetabolites, Antineoplastic; D013501:Surface-Active Agents; D012710:Serum Albumin, Bovine; D005472:Fluorouracil